藍豐生化(002513.SZ):旭合科技收到政府補助2146.22萬元
格隆匯3月31日丨藍豐生化(002513.SZ)公佈,公司的控股子公司安徽旭合新能源科技有限公司(簡稱“旭合科技”)與中新蘇滁高新技術產業開發區管理委員會、中新蘇滁(滁州)開發有限公司簽訂的《“10GW超高效N型光伏電池及組件”項目補充協議書》相關條款,旭合科技於近日收到中新蘇滁高新技術產業開發區管理委員會下發的固定資產投資補助款人民幣2146.22萬元,佔上市公司最近一期經審計淨資產85.10%,補助形式爲現金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.